<DOC>
	<DOCNO>NCT00261586</DOCNO>
	<brief_summary>The purpose study compare several analgesic give approve daily dos combination daily cardioprotective dose aspirin ( 81 mg ) , study bleed property effect stomach healthy volunteer .</brief_summary>
	<brief_title>A Safety Trial Compare Different Analgesics Combination With Low Dose Aspirin Study Their Bleeding Properties Their Effects Stomach</brief_title>
	<detailed_description>The purpose randomize , multiple-dose , single-blind , parallel-group study examine healthy volunteer effect analgesic give approve daily dos addition daily cardio-protective dos aspirin ( 81 mg ) stomach . All subject examine endoscopically receive study medication , end treatment Day 9 . Each subject take 81 mg aspirin daily plus one following treatment take daily Days 1 8 : four dos acetaminophen 1000 mg , three dos ibuprofen 400 mg , two dos naproxen sodium ( 440 mg morning 220 mg evening ) , four dos aspirin 650 mg , two dos celecoxib 200 mg , one dose rofecoxib 25 mg , additional study medication . On Day 9 , one dose aspirin 81 mg one dose assign treatment drug take prior endoscopy . The primary endpoint study effect analgesic inhibition COX-1 activity aspirin , injury stomach mucosa , determine direct endoscopic observation . Safety assessment consist routine monitoring adverse event , well endoscopic examination gastric mucosa erosion ulceration occur treatment phase . The study hypothesis effect acetaminophen stomach differ effect ibuprofen , naproxen , aspirin , celecoxib , rofecoxib . 81 mg aspirin 1of 7 treatment 8 day : acetaminophen 1000mg 4xday , ibuprofen 400mg 3xday , naproxen 440mg morning 220mg evening , additional study medication , aspirin 650mg 4xday , celecoxib 200mg 2xday , rofecoxib 25mg 1xday . On Day 9 , 1 dose aspirin &amp; 1 dose study drug endoscopy .</detailed_description>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Rofecoxib</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>In general good health normal hemostatic ( blood coagulation ) parameter able swallow study medication nonsmoker negative H. pylorus infection female , must pregnant breast feeding Have take antiinflammatory drug within one week study entry , analgesic within 24 hour baseline endoscopy , systemic steroid within 6 week study entry unable tolerate oral drug gastrointestinal disease prior gastrointestinal surgery could interfere study medication unable understand follow instruction medical condition clinically significant abnormal laboratory result may relevant participation study</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>aspirin</keyword>
	<keyword>analgesic</keyword>
	<keyword>cyclooxygenase activity</keyword>
	<keyword>non-steroidal antiinflammatory drug</keyword>
</DOC>